| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2023 ( Subtotal = $1 ) |
| 2023 | 2021 | THE RAND CORPORATION | 1776 MAIN ST | SANTA MONICA | CA | 90401 | LOS ANGELES | USA | Trans-NIH Research Support | 000 | 2 | 5/12/2023 | SUPPLEMENT FOR EXPANSION | $1 |
|
| Issue Date FY: 2022 ( Subtotal = -$644 ) |
| 2022 | 2021 | RAND CORP | 1776 MAIN ST | SANTA MONICA | CA | 90401 | LOS ANGELES | USA | Trans-NIH Research Support | 000 | 2 | 7/27/2022 | SUPPLEMENT FOR EXPANSION | -$644 |
|
| Issue Date FY: 2021 ( Subtotal = $100,000 ) |
| 2021 | 2021 | RAND CORPORATION, THE | 1776 MAIN ST | SANTA MONICA | CA | 90401 | LOS ANGELES | USA | Trans-NIH Research Support | 000 | 2 | 4/12/2021 | SUPPLEMENT FOR EXPANSION | $100,000 |
|
| Issue Date FY: 2020 ( Subtotal = $209,523 ) |
| 2020 | 2020 | RAND CORPORATION, THE | 1776 MAIN ST | SANTA MONICA | CA | 90401 | LOS ANGELES | USA | Cancer Detection and Diagnosis Research | 000 | 2 | 1/31/2020 | NON-COMPETING CONTINUATION | $209,523 |
|
| Issue Date FY: 2019 ( Subtotal = $223,312 ) |
| 2019 | 2019 | RAND CORPORATION, THE | 1776 MAIN ST | SANTA MONICA | CA | 90401 | LOS ANGELES | USA | Cancer Detection and Diagnosis Research | 000 | 1 | 2/6/2019 | NEW | $223,312 |
|
|